Author

Laila Carolina Abu Esba

Clinical Pharmacist, Ministry of National Guard Health Affairs, King Abdulaziz Medical City - Cited by 209 - Pharmacy

Biography

Dr. Laila Carolina Abu Esba completed her bachelors from Södertörn University in the field of infectious diseases and masters from University of Toronto in the field of pharmacy. Currently she is working at National Guard Health Affairs in the Pharmaceutical Care Department. She has 20 publications and 22 citations. Her research interests are in Pharmacy, Health Systems, Pharmacovigilance.  
Title
Cited by
Year
Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort study
LC Abu Esba, RA Alqahtani, A Thomas, N Shamas, L Alswaidan, ...Infectious diseases and therapy 10, 253-268, 2021202
90
2021
Reported Adverse Effects following COVID-19 Vaccination at a Tertiary Care Hospital, Focus on Cerebral Venous Sinus Thrombosis (CVST)
LA Esba, M Al JeraisyExpert Review of Vaccines, 2021202
31
2021
Adoption of a personal health record in the digital age: cross-sectional study
CC Yousef, A Thomas, AO Alenazi, S Elgadi, LC Abu Esba, A AlAzmi, ...Journal of medical Internet research 22 (10), e22913, 2020202
18
2020
Health care providers’ acceptance of a personal health record: cross-sectional study
CC Yousef, TM Salgado, A Farooq, K Burnett, LE McClelland, ...Journal of medical Internet research 23 (10), e31582, 2021202
12
2021
Acute kidney injury in pediatric treated with vancomycin and piperacillin-tazobactam in tertiary care hospital
M Al Nuhait, LC Abu Esba, K Al Harbi, M Al Meshary, RT BustamiInternational Journal of Pediatrics 2018, 1-7, 2018201
10
2018
Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented
MS Laila Carolina Abu Esba BSc, MSc, PharmD Ghada Al Mardawi BSc, SSC‐PhP ...The Journal of Clinical Pharmacy and Therapeutics, 202010202
10
2020
Predicting Patients’ Intention to Use a Personal Health Record Using an Adapted Unified Theory of Acceptance and Use of Technology Model: Secondary Data Analysis
CC Yousef, TM Salgado, A Farooq, K Burnett, LE McClelland, A Thomas, ...JMIR medical informatics 9 (), e30214, 2021202
8
2021
An annual formulary review strategy implemented by a Saudi health system
LCA EsbaPharmacy and Therapeutics 41 (8), 13, 2016201
5
2016
Fixed dose combinations: A formulary decision guide
LCA Esba, C Yousef, S Ismail, M Halim, H Almodaimegh, ...Health Policy and Technology 10 (2), 100500, 2021202
4
2021
Pharmacy and therapeutics committee preparedness plan for covid-19
LC Abu Esba, HA Al-Abdulkarim, A Alrushidan, M Al HarbiGlobal Journal on Quality and Safety in Healthcare 3 (2), 55-6, 2020202
4
2020
Saudi Consensus for GLP-1 RAs Switching Guidance: Consensus Report
ERI Saud Alsifri, Hussein Elbadawi, Fahad Alsabaan, Abdulraouf Almahfouz ...International Journal of Clinical Medicine 13 (1), 0
2
2022
Apixaban Use in Patients with Protein C and S Deficiency: A Case Series and Review of Literature
BHA Al Sulaiman K , Alsuwayyid F, Alrashidi A, Alhijris M, Almutairi F ...Journal of Blood Medicine 13, 105-111, 0
2
2022
Complementing ADR data by utilizing electronic health records: experience form a tertiary care hospital in Saudi Arabia
LCA EsbaJ Pharmacovigil 7 (1), 01901
2
2019
An Institutional Guide for Formulary Decisions of Biosimilars
CY Sherin Ismail, Laila Abu Esba, Mansoor Khan, Hana Al-Abdulkarim, Hind ...Hospital Pharmacy, 20222202
2
2022
P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System
LCA Esba, H Almodaimegh, A Alhammad, M Ferwana, C Yousef, S IsmailPharmacy and Therapeutics 43 (5), 93, 01801
2
2018
Linezolid vs vancomycin in induced thrombocytopenia
LCAE Dimah Al-Harbi, Abdulrahman Al Turaiki, Ayshah Alshngeetee,Haya Aldabas ...Infectious Diseases and Therapy (3), 2022202
1
2022
Can’t Find the Antidote: A Root Cause Analysis
LC Abu Esba, G Mardawi, M Al DeebFrontiers in Pharmacology, 2022202
1
2022
A case of linezolid-associated hyponatremia in a Saudi patient
MA AlMolaiki, LC Abu EsbaBiomed J Sci Tech Res 3, 03-05, 20920
1
2019
Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region
B Elezbawy, AN Fasseeh, E Fouly, M Tannira, H Dalle, S Aderian, ...Dermatology and Therapy 3 (), 3-46, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=ZvrfwHoAAAAJ&hl=en

Cited by
Citations 209
h-index 7
i10-index 6
Recommended Journals
Open Access Journals